UTHR Stock United Therapeutics (UTHR, $366.61) Moving Average Convergence Divergence (MACD) Histogram turned positive on January 8, 2025

GET DAILY SIGNALS

Get AI intraday signals

UTHR - United Therapeutics Corp

MACD signal

View

Odds of UP Trend

Price: $366.61

Daily change: +$4.28 (+1.18%)

Daily volume: 252.7K

Capitalization: $16.4B

Industry: Biotechnology

UTHR in +3.16% Uptrend, rising for three consecutive days on January 08, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UTHR advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 21, 2025. You may want to consider a long position or call options on UTHR as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for UTHR just turned positive on January 08, 2025. Looking at past instances where UTHR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

UTHR moved above its 50-day moving average on January 22, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UTHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for UTHR entered a downward trend on December 23, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UTHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.714) is normal, around the industry mean (15.535). P/E Ratio (16.293) is within average values for comparable stocks, (88.887). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (1.856). UTHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (6.575) is also within normal values, averaging (266.701).